Ken Griffin Amphastar Pharmaceuticals, Inc. Transaction History
Citadel Advisors LLC
- $483 Billion
- Q2 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 7,400 shares of AMPH stock, worth $359,418. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,400
Previous 14,900
50.34%
Holding current value
$359,418
Previous $654,000
54.74%
% of portfolio
0.0%
Previous 0.0%
Shares
24 transactions
Others Institutions Holding AMPH
# of Institutions
283Shares Held
35.2MCall Options Held
25.5KPut Options Held
24.8K-
Black Rock Inc. New York, NY5.94MShares$289 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.67MShares$130 Million0.0% of portfolio
-
Td Asset Management Inc2.14MShares$104 Million0.1% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA1.94MShares$94.5 Million0.19% of portfolio
-
Neuberger Berman Group LLC New York, NY1.62MShares$78.8 Million0.05% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $2.38B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...